Institutional Ownership
Crispr Therapeutics AG
CUSIP H17182108NAMEN AKTCRSPQ1 2026
13D / 13G Filings
44
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
14.6%
Max % of class reported
Institutional Holders
478
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
44 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Orbis Investment Management Ltd | 13G/A | 6.2% | 5.95M | SEC |
| 2 | Feb 5, 2026 | Capital International Investors | 13G/A | 1.2% | 1.19M | SEC |
| 3 | Nov 14, 2025 | Orbis Investment Management Ltd | 13G | 5.5% | 4.98M | SEC |
| 4 | Nov 4, 2025 | Ark Investment Management LLC | 13G/A | 10.8% | 9.79M | SEC |
| 5 | Jul 17, 2025 | Blackrock, Inc. | 13G | 6.9% | 5.93M | SEC |
| 6 | May 14, 2025 | Ark Investment Management LLC | 13G/A | 11.8% | 10.17M | SEC |
| 7 | May 13, 2025 | Capital International Investors | 13G/A | 7.4% | 6.33M | SEC |
| 8 | Feb 14, 2025 | Ark Investment Management LLC | 13G/A | 10.5% | 8.97M | SEC |
| 9 | Jan 10, 2025 | Ark Investment Management LLC | 13G/A | 8.8% | 7.50M | SEC |
| 10 | Dec 10, 2024 | Ark Investment Management LLC | 13G/A | 10.7% | 9.12M | SEC |
34 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Crispr Therapeutics AG.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ark Investment Management LLC | 11.31M | $538.19M |
| 2 | Blackrock, Inc. | 7.68M | $365.34M |
| 3 | Orbis Allan Gray Ltd | 6.11M | $290.46M |
| 4 | Capital World Investors | 4.73M | $224.77M |
| 5 | State Street Corp | 3.98M | $189.45M |
| 6 | Gsk PLC | 3.22M | $153.21M |
| 7 | Geode Capital Management, LLC | 2.38M | $113.10M |
| 8 | Sr One Capital Management, LP | 2.04M | $96.98M |
| 9 | Fmr LLC | 1.95M | $92.98M |
| 10 | Sumitomo Mitsui Trust Group, Inc. | 1.85M | $88.19M |